Here are relevant reports on : agriculture-biotechnology-market
-
Gel Documentation Systems Market by Product (Instruments (Digital), Software), Light Source (Laser, LED, UV), Detection (Chemiluminescence), Application (Nucleic Acid), End User (Academic Institutes, Biotechnology Companies) & Region - Global Forecast to 2023
The gel documentation systems market is projected to reach USD 304 million by 2023, at a CAGR of 3.3%. Growth in the gel documentation systems market is mainly driven by the increasing prevalence of infectious and chronic disease, and rising research & development expenditure in the pharmaceutical and biotechnology companies. The major players in the gel documentation systems market are GE Healthcare (US), Bio-Rad Laboratories, inc. (US), Thermo Fisher Scientific (US), LI-COR Biosciences (US), Endress+Hauser Management AG (Switzerland), Vilber Lourmat (France), Scientific Digital Imaging plc (UK), Bio-Techne (US), Cleaver Scientific (US), and Azure Biosystems (US).
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Asia Pacific Chromatography Resins Market by Technique (Ion Exchange (Cation, Anion), Affinity, Hydrophobic Interaction, Mixed Mode), Application (Pharmaceutical & Biotechnology), Type (Natural, Synthetic, Inorganic Media), and Country - Forecast to 2030
The Asia Pacific chromatography resins market size was USD 884.5 million in 2025 and is projected to reach USD 1,422.9 million by 2030, at a CAGR of 9.97%, between 2025 and 2030. The Key Players Danaher Corporation (Singapore), Tosoh Corporation (Japan), and Mitsubishi Chemical Group Corporation (Japan), among others.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Pipette Calibrators Market by Type (Devices, Software), Channel Type, Method (Gravimetry, Photometry), Application (Research (Drug Discovery), Clinical Diagnostics), End User (Pharmaceutical & Biotechnology), & Region - Global Forecast to 2029
The global pipette calibrators market, valued at US$255 million in 2022, stood at US$286 million in 2023 and is projected to advance at a resilient CAGR of 6.5% from 2023 to 2028, culminating in a forecasted valuation of US$391 million by the end of the period. The growth in this market is attributed to the increasing need for pipettes in research facilities, and growing use of portable handheld calibration devices, and adoption of cloud-based calibration management. However, presence of alternative simple methods or techniques could restrain the growth of this market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020
The expression vectors market is expected to reach $317.1 Million by 2020 from $242.7 Million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. Major factors driving the growth of this market include the increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. On the other hand, high market consolidation, which increases entry barriers, and high cost of protein therapy are the major factors restraining the growth of this market.
- Published: June 2015
- Price: $ 4950
- TOC Available:
-
Bioprocess Validation Market by Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter Element, Bioreactors), End-User (CDMO, Biotechnology & Pharmaceutical Companies) & Region - Global Forecasts to 2024
The global bioprocess validation market size is projected to reach USD 360 million by 2024, at a CAGR of 14.6%. The prominent players operating in this market are Merck KGaA (Germany), Sartorius Stedim Biotech (Sartorius AG) (France), Pall Corporation (US), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Cobetter Filtration Equipment Co., Ltd. (China), Toxikon Corporation (US), DOC S.r.l. (Italy), MEISSNER FILTRATION PRODUCTS, INC. (US), and Thermo Fisher Scientific (US).
- Published: July 2019
- Price: $ 4950
- TOC Available:
-
CIP Chemicals Market by Chemistry, Process Type (Single-use Cleaning and Recirculated Cleaning), End-use Industry (Chemicals, Food & Beverage, Pharmaceutical & Biotechnology, Cosmetics, Textiles), and Region - Global Forecast to 2029
The CIP chemicals market is expected to grow from USD 15.60 billion in 2024 to USD 24.00 billion by 2029, at a CAGR of 9.0% during the forecast period. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the CIP chemicals market. These are ALFA LAVAL (Sweden), BASF (Germany), Ecolab (US), Novozymes (Denmark), STERIS (US), Solvay (Belgium), KIC KRONES Internationale Cooperations-Gesellschaft mbH (Germany), Diversey, Inc (US), Chemtex Speciality Limited (India), and Keller & Bohacek GmbH & Co. KG (Germany).
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
North America Chromatography Resins Market by Technique (Ion Exchange (Cation and Anion), Affinity, Hydrophobic Interaction, Mixed Mode), Application (Pharmaceutical & Biotechnology), Type (Natural, Synthetic, Inorganic Media), and Country - Forecast to 2030
North America Chromatography Resins Market
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Protein Binding Assays Market by Technology (Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023
The major players operating in the global protein binding assay market are Thermo Fisher (US), HTDialysis (US), Merck (US), GE Healthcare (US), and Absorption Systems (US). The global protein binding market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at a CAGR of 10.7%. The growing number of drug discovery activities, the minimizing drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving the growth of this market. The key players in the global protein binding assays market are HTDialysis (US), Thermo Fisher Scientific (US), Merck (Germany), and Sovicell (Germany).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
HPC Data Management Market in Life Sciences By Products & Services (Data Analysis, Cloud Computing), Applications (NGS, Microscopy, Chromatography), End User (Pharmaceutical & Biotechnology, Hospitals) - Global Forecast to 2024
The HPC Data Management Market in life sciences is projected to reach USD 41.1 billion by 2024, at a CAGR of 17.1%. The growth of this market is majorly driven by the growing demand for data storage and management solutions due to extensive amount of data generated through large number of research activities. However, the high cost of implementation and regulatory hurdles are major factors restraining the growth of this market.Dell Technologies Inc. (US), Advanced Micro Devices, Inc. (US), Cray, Inc. (US), Cisco Systems, Inc. (US), IBM Corporation (US), Intel Corporation (US), Lenovo Group Limited (China), Hewlett Packard Enterprise Company (US).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026
The global aptamers market growth is primed to transition from $151 million in 2021 to $342 million by 2026, showcasing a strong CAGR of 17.7%. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market.
- Published: November 2021
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
